Erika shares her experience with the stigma surrounding type 1 and type 2 diabetes, emphasizing that neither group should feel shame. Scott encourages a broader perspective on diabetes treatments, highlighting the potential benefits of GLP-1 medications for type 1s. Both discuss the importance of unity within the diabetes community and the need to move past outdated narratives.
